Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic gene targeting

R J Yáñez1, A C Porter

  • 1Gene Targeting Group, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

Gene Therapy
|May 14, 1998
PubMed
Summary
This summary is machine-generated.

Gene targeting offers ideal gene therapy for single-gene disorders but faces low efficiency challenges. Improvements in targeting techniques and somatic cell growth are crucial for therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.

Cell death and differentiation·2013
Same author

Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.

European journal of pharmacology·2001
Same author

The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Pharmacology & therapeutics·2001
Same author

Elucidating the role of muscarinic receptors in psychosis.

Life sciences·2001
Same author

Correcting a deficiency.

Molecular therapy : the journal of the American Society of Gene Therapy·2001
Same author

A 'select and swap' strategy for the isolation of clones with tightly regulated transgenes.

European journal of biochemistry·2001
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Gene targeting utilizes homologous recombination for precise genomic alterations.
  • Accurate correction of genetic defects via gene targeting presents ideal gene therapy potential for single-gene disorders.
  • Current low efficiency of gene targeting in human cells limits its therapeutic viability.

Purpose of the Study:

  • To review the challenges associated with gene therapy using gene targeting.
  • To critically overview recent advancements in gene targeting methodologies.
  • To enhance understanding of the recombination processes underlying gene targeting.

Main Methods:

  • Review of existing literature on gene targeting and homologous recombination.
  • Analysis of recent developments in gene targeting techniques.

Related Experiment Videos

  • Examination of underlying homologous and nonhomologous recombination processes.

    • Main Results:

    • Gene targeting efficiency remains a significant hurdle for in vivo gene therapy.
    • Ex vivo approaches may be more feasible but require improved somatic stem cell isolation and growth.
    • Recent developments show promise in advancing gene targeting techniques.

    Conclusions:

    • Dramatic improvements in gene targeting efficiency are necessary for practical in vivo applications.
    • Progress in somatic stem cell biology and targeting efficiency could enable ex vivo gene therapy.
    • Enhanced understanding of recombination mechanisms is key to advancing gene targeting technologies.